WCM
ARKG icon

WealthTrak Capital Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

WealthTrak Capital Management’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-25
Closed -$609 – 143
2025
Q2 		$609 Hold
25
– – ﹤0.01% 609
2025
Q1 		$519 Hold
25
– – ﹤0.01% 645
2024
Q4 		$589 Buy
+25
New +$615 ﹤0.01% 532

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

WealthTrak Capital Management's ARKG Position: Q3 2025 in Review

WealthTrak Capital Management sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2025, closing a stake of 25 shares — an estimated $609 sold.

WealthTrak Capital Management first reported a position in ARKG in Q4 2024 and held it in 3 quarters. The position peaked at $609 in Q2 2025. 234 funds tracked by Wall St. Rank hold ARKG as of Q3 2025.

  • WealthTrak Capital Management reported no remaining ARK Genomic Revolution ETF position as of Q3 2025 after selling out during the quarter.
  • WealthTrak Capital Management sold 25 ARK Genomic Revolution ETF shares in Q3 2025, an estimated $609.
  • WealthTrak Capital Management first reported a position in ARK Genomic Revolution ETF in Q4 2024 and held it in 3 quarters.
  • WealthTrak Capital Management's ARK Genomic Revolution ETF position peaked at $609 in Q2 2025.
  • 234 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2025.

Based on WealthTrak Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.